Blood-born tissue factor in cardiovascular disease: where are we now?

被引:0
|
作者
Vincenzo Toschi
机构
[1] A.O. Ospedale San Carlo Borromeo,Department of Hematology and Blood Transfusion, Thrombosis Center
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 5
页数:2
相关论文
共 50 条
  • [21] Autologous blood in obstetrics: where are we going now?
    Liumbruno, Giancarlo Maria
    Liumbruno, Chiara
    Rafanelli, Daniela
    BLOOD TRANSFUSION, 2012, 10 (02) : 125 - 147
  • [22] Newborn screening and renal disease: where we have been; where we are now; where we are going
    Merritt, J. Lawrence, II
    Askenazi, David
    Hahn, Si Houn
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1453 - 1464
  • [23] Newborn screening and renal disease: where we have been; where we are now; where we are going
    J. Lawrence Merritt
    David Askenazi
    Si Houn Hahn
    Pediatric Nephrology, 2012, 27 : 1453 - 1464
  • [24] Introductory paper: Cardiovascular reactivity at a crossroads: Where are we now?
    Phillips, Anna C.
    Hughes, Brian M.
    BIOLOGICAL PSYCHOLOGY, 2011, 86 (02) : 95 - 97
  • [25] Menopausal Hormone Therapy and Cardiovascular Risk: Where are We Now?
    Anagnostis, Panagiotis
    Paschou, Stavroula A.
    Katsiki, Niki
    Krikidis, Dimitrios
    Lambrinoudaki, Irene
    Goulis, Dimitrios G.
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (06) : 564 - 572
  • [26] Gene therapy for Parkinson's disease: where are we now and where are we going?
    Forsayeth, John
    Bankiewicz, Krystof S.
    Aminoff, Michael J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1839 - 1845
  • [27] Drug Development for Alzheimer's Disease: Where Are We Now and Where Are We Headed?
    Sabbagh, Marwan N.
    AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2009, 7 (03): : 167 - 185
  • [28] Microbiome-Based Diagnostics for Disease: Where Are We Now and Where Are We Headed?
    Yarbrough, Melanie L.
    Dumm, Rebekah E.
    Bry, Lynn
    Kelly, Brendan J.
    Schwartz, Drew
    Uberoi, Aayushi
    CLINICAL CHEMISTRY, 2024, 70 (06) : 792 - 797
  • [29] Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
    Naseer, Maliha
    Poola, Shiva
    Ali, Syed
    Samiullah, Sami
    Tahan, Veysel
    CURRENT CLINICAL PHARMACOLOGY, 2020, 15 (03): : 216 - 233
  • [30] Behavioral healthy nutrition and physical activity counseling in cardiovascular disease prevention: where we are now?
    Panagiotakos, Demosthenes B.
    Kouvari, Matina
    HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (05) : 534 - 536